<- Go home

Added to YB: 2016-09-15

Pitch date: 2016-09-15

HZNP:US [bullish]

Horizon Therapeutics Public Limited Company

+691.7%

current return

Author Info

No bio for this author

Company Info

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases.

Market Cap

$26.6B

Pitch Price

$14.69

Price Target

N/A

Dividend

N/A

EV/EBITDA

39.41

P/E

61.85

EV/Sales

7.37

Sector

Biotechnology

Category

N/A

Show full summary:
Horizon Therapeutics Public Limited Company HZNP:US

A summary for this pitch has not been created yet.

Read full article (0 min)